Ketogenic diet therapy for patients with acromegaly
Official title: Ketogenic Diet Therapy in Patients With Acromegaly
Run by Erasmus Medical Center · NCT06949891 · Data updated 2026-11-12
This study tests whether a ketogenic diet can help people with acromegaly lower their growth hormone levels and improve their quality of life compared to a Mediterranean diet.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | December 31, 2027 |
| Study ends | May 1, 2028 |
| Registry record updated | April 29, 2025 |
| Trial ID | NCT06949891 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with diagnosed acromegaly and elevated IGF-I levels due to a pituitary tumor.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have undergone recent pituitary surgery or radiotherapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of a ketogenic diet compared to a Mediterranean diet in patients diagnosed with acromegaly due to a pituitary adenoma. Acromegaly is characterized by excessive growth hormone production, leading to various health complications. The trial aims to assess whether dietary interventions can help normalize growth hormone and IGF-1 levels, potentially improving patient outcomes. Participants will be monitored for changes in metabolic parameters and overall quality of life.
Why it matters
Potential benefit: If successful, this approach could provide a novel dietary management strategy to improve health outcomes for patients with acromegaly.
How similar studies have gone: While dietary interventions in acromegaly are less commonly explored, preliminary studies suggest potential benefits, indicating this approach may be novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, 18 years or older * Diagnosis of acromegaly based on elevated GH and/or IGF-I levels due to a pituitary tumor * IGF-I levels above 80% upper limit of the normal range (xULN)) on a stable medication dose for at least 4 months * Written informed consent Exclusion Criteria: * Pregnancy or breastfeeding * Pegvisomant treatment * Has undergone pituitary surgery or radiotherapy within 6 months prior to s study entry; * It is anticipated that the patient will receive pituitary surgery or radiotherapy during the study; * History or presence of epilepsy; * Participation in a trail of an experimental drug or device within 30 days prior to screening; * Has a mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study * Screening HbA1c \> 6,5%; * Use of antidiabetic medication other than Metformin
Where it's running
-
Erasmus Medical Center
Rotterdam, Netherlands Recruiting
Study contacts
- Study coordinator: Kirsten A. Berk, Dr.
- Email: k.berk@erasmusmc.nl
- Phone: +31 0107033055
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Managing pasireotide-related high blood sugar in acromegaly with a ketogenic diet
This study tests whether a very-low carbohydrate ketogenic diet can help lower HbA1c and fasting glucose in adults with acromegaly who develop high blood sugar while taking pasireotide.
-
Diet patterns and gut health: effects of ketogenic, vegetarian, and habitual diets
This 12-week randomized trial tests whether ketogenic, vegetarian, or habitual diets change gut microbiota, inflammation, gene expression, and metabolic markers in healthy adults.
-
Ketogenic Diet and Alcohol Intoxication: Can ketosis affect brain function and alcohol response
This study tests whether a 4‑week ketogenic diet changes how the brain works and how the body handles alcohol in adults who drink regularly.
-
Pasireotide LAR and bone health in adults with acromegaly
This study will test whether switching adults with uncontrolled acromegaly to pasireotide LAR changes bone turnover and the risk of vertebral fractures.
-
Identifying genetic factors that predict dietary intervention success in IBS
This study is trying to find out if certain genes can help predict how well people with Irritable Bowel Syndrome will respond to a special diet that combines low FODMAP and Mediterranean foods.
-
Using a mobile app to help university students follow the Mediterranean diet
This study tests if a mobile app can help university students stick to the Mediterranean diet better than those who don’t use the app.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.